Ranolazine Tablet, Extended Release
Product Images NDC 63304-017

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 63304-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ranolazine-1000mg-label (Spl Ranolazine 1000mg Label)

Label for Ranolazine Extended-Release Tablets 1000 mg by Sun Pharmaceutical Industries, Inc. The label states the tablets are to be swallowed whole without crushing, breaking, or chewing. The package contains 60 tablets and is for oral use with 1000 mg per tablet.*

FDA Label Image

Spl-ranolazine-500mg-label (Spl Ranolazine 500mg Label)

Label for Ranolazine Extended-Release Tablets 500 mg by Sun Pharmaceutical Industries, Inc. The label indicates 60 tablets per package, with instructions to swallow whole without crushing, breaking, or chewing. It includes a barcode, NDC number 63304-017-60, and storage instructions.*

FDA Label Image

Spl-ranolazine-er-tablets-structure (Spl Ranolazine Er Tablets Structure)

Chemical structure diagram of ranolazine, illustrating its molecular framework with rings and functional groups as commonly depicted in pharmaceutical chemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.